Navigation Links
Molecular Devices and Cytena Partner to Launch the CloneSelect Single-Cell Printer
Date:9/19/2017

Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This novel system utilizes sophisticated microfluidics-based technology and real-time image analysis to isolate single cells and provide visual documentation of monoclonality for use in cell line development.

Clonal cell line development has been receiving increasing focus and investment as a method for producing targeted therapeutics. As a part of the development process, cells producing high amounts of the antibody of interest need to be selectively isolated to be able to move them forward for additional screening. The CloneSelect SCP accelerates antibody discovery by allowing for automated isolation of single cells into standard 96- and 384- well plates for a wide range of cell types.

“We are very excited about this product and how it allows us to expand our toolset in the fast-growing biotherapeutics market,” said Greg Milosevich, President at Molecular Devices. “Our customers have been seeking ways to bring biologics and biosimilars to market more quickly, and we continue to invest in technologies that accelerate time-consuming process steps.”

Traditional methods for single cell sorting in cell line development suffer from drawbacks including low sorting efficiencies, low cell viabilities, and limited evidence of monoclonality. The CloneSelect SCP overcomes these limitations by screening for both single cells and for cell morphology immediately prior to gently depositing in the well, ensuring high cell viability. The use of sterilized, disposable cartridges also ensures the prevention of any cross-contamination or need for in-situ sterilization. During deposition, images of single cells are provided, giving customers the confidence of knowing their cell lines are monoclonal.

“This partnership will accelerate the continued growth of our business,” said Jonas Schoendube, CEO at Cytena. “We are looking forward to having additional commercial capabilities in the United States and Canada as a result of our work with Molecular Devices, and we believe that this relationship will bring superior service to our customer base.”

About Molecular Devices, LLC
Molecular Devices is one of the world's leading providers of high-performance bioanalytical measurement systems, software and consumables and is dedicated to helping customers unravel the complexity of biological systems. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These innovative instruments, combined with scientific expertise, assays, and analytics tools for protein and cell biology enable scientists to explore life’s most important questions. The company is headquartered in Silicon Valley, California with offices around the globe.

About cytena, GmbH
Cytena GmbH is an established start-up in the field of life science, founded in 2014 in Freiburg, Germany and focuses on single-cell technologies. The Cytena team has developed the patented single-cell printing technology that enables deposition of single cells in a documented, viable and sterile workflow. The Single-Cell Printers™ are manufactured in Germany and marketed worldwide. In 2017, the majority of the top ten pharma companies use Single-Cell Printers to ensure fast antibody development.

For more information, visit: http://www.moleculardevices.com/CloneSelectSCP

Read the full story at http://www.prweb.com/releases/2017/09/prweb14708863.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, Former Head of Roche Molecular Diagnostics
2. Panel Convened at Society of Nuclear Medicine and Molecular Imaging Meeting Say MO-99 Supplies are Secure
3. Molecular Devices Introduces SpectraMax DuoLuc Reporter Assay Kit
4. Molecular or Immunoassay? Which Technology Will Win the Race for the Point of Care Diagnostics Market?
5. 2017 Foresight Fellows Announced in Molecular Machines, Space, Longevity, Artificial Intelligence
6. Molecular Assemblies Appoints Floyd E. Romesberg from The Scripps Research Institute to Scientific Advisory Board
7. Caprion Biosciences wird Kurzlehrgang und Poster bei Molecular Medicine Tri-Conference in San Francisco präsentieren
8. Global Biomarkers Technologies, Markets and Companies Report 2017-2025: Proteomics, Metabolomics, Molecular Diagnostics, Drug Discovery, Clinical Trials, and Bioinformatics - Research and Markets
9. Global Molecular Diagnostics Analysis Report 2010-2016: Deal Trends, Key Players, Top Deal Values & Deals Financials - Research and Markets
10. Benchling Announces First Of Its Kind Molecular Biology 2.0 Software Enabling Scientists To Run Thousands Of Experiments At Once
11. Global Molecular Diagnostics Research Report 2017: Focus on Technologies, Applications, Regulations, Markets and Companies to 2025 - Research and Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its ... 2018 in San Francisco, CA. The Summit brings together current and former FDA office ... directors and government officials from around the world to address key issues in device ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology:
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
Breaking Biology News(10 mins):